Advertisement
Canada markets close in 2 hours 41 minutes

  • S&P/TSX

    22,037.78
    +165.82 (+0.76%)
     

  • S&P 500

    5,064.49
    +53.89 (+1.08%)
     

  • DOW

    38,477.90
    +237.92 (+0.62%)
     

  • CAD/USD

    0.7319
    +0.0018 (+0.25%)
     

  • CRUDE OIL

    83.05
    +1.15 (+1.40%)
     

  • Bitcoin CAD

    91,087.73
    +388.34 (+0.43%)
     

  • CMC Crypto 200

    1,436.59
    +21.83 (+1.54%)
     

  • GOLD FUTURES

    2,343.00
    -3.40 (-0.14%)
     

  • RUSSELL 2000

    2,002.92
    +35.45 (+1.80%)
     

  • 10-Yr Bond

    4.5760
    -0.0470 (-1.02%)
     

  • NASDAQ

    15,671.49
    +220.18 (+1.43%)
     

  • VOLATILITY

    16.25
    -0.69 (-4.07%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

Medivation board rejects Sanofi's $9.3 billion takeover offer

Reuters
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo (Reuters)

(Reuters) - Medivation Inc said on Friday its board rejected an unsolicited $9.3 billion (6.35 billion pounds) takeover proposal from Sanofi SA , saying the offer undervalued the company and its pipeline of oncology drugs. The French drugmaker went public with its $52.50 per share cash offer on Thursday. Medivation's shares were trading at $56.41 before market open on Friday. "Our Board strongly believes that Medivation's business plan will deliver value to our stockholders that is far superior to Sanofi's offer and unanimously rejects your proposal," Medivation said in statement. (Reporting by Amrutha Penumudi in Bengaluru; Editing by Saumyadeb Chakrabarty)